No abstract

Summary

In this article, we feature photographs and cellphilms produced by 13 girls and young women (aged 13 to 19) from urban, rural, and Indigenous areas of Quebec, Canada during the COVID-19 pandemic. Framed within girls’ studies, we present girls’ and young women’s creations and co-analysis about wellbeing during a period of lockdown. We explore how girls and young women restructured their routines at home as well as negotiated motivation and the pressure to be productive. We note that girls had more time than usual for creative activities and self-discovery and that they engaged with the politics of the pandemic and advocated for collective forms of wellbeing. Importantly, girls reported that participating in this research improved their wellbeing during this lockdown.

Objectives: To investigate if MS subjects treated with PRF 10mg BID will show a greater benefit from active enabled motor training compared with placebo. Methods: Single center, phase 4, pilot, placebo-controlled, double-blind 18 weeks study. Fifteen patients were randomized to receive PRF 10 mg BID and fifteen to received placebo BID. All patients participated in active enabled motor training of 3 sessions of 1 hour/week for 6 weeks. Patients were evaluated at -4, 0, 6 and 14 weeks using the timed 8 meters walk (8 MW), the 6 minute walk (6 MW) and the timed sit to stand (STS). Results: The PRF treated group achieved a higher mean percent improvement from baseline in all tasks at both 6 and 14 week time points. The difference reached statistical significance (mean difference of 14.29, p=0.046) for the 8MW at the 14 week time point. A higher incidence of responders (>20% improvement from baseline) was seen in the PRF treated group at 6 weeks on the 8MW (odds ratio [OR] of 2.31) and the 6MW (OR of 1.63), and at 14 weeks on the 8MW and the STS (OR of 2.0). Conclusions: PRF in MS patients appears to enhance the benefit of active enabled motor training and to better sustain it over the following 8 weeks.